BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16837128)

  • 1. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
    Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
    Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
    Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
    Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Study of Heterogeneous Mismatch Repair Expression in Solid Tumors Reveals Different Immunohistochemical Patterns and Distinct Genetic Mechanisms.
    Wang J; Zhang Z; Cai Y; Lu J; Zhang H; Pang J; Wu H; Liang Z
    Am J Surg Pathol; 2024 Apr; 48(4):417-425. PubMed ID: 37997470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare single-nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome.
    Mirabdolhosseini SM; Yaghoob Taleghani M; Rejali L; Sadeghi H; Fatemi N; Tavallaei M; Famil Meyari A; Saeidi N; Ketabi Moghadam P; Sadeghi A; Asadzadeh Aghdaei H; Zali MR; Nazemalhosseini Mojarad E
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1930. PubMed ID: 37919876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.
    Kadiyska TK; Kaneva RP; Nedin DG; Alexandrova AB; Gegova AT; Lalchev SG; Christova T; Mitev VI; Horst J; Bogdanova N; Kremensky IM
    World J Gastroenterol; 2006 Dec; 12(48):7848-51. PubMed ID: 17203532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.
    Deihimi S; Lev A; Slifker M; Shagisultanova E; Xu Q; Jung K; Vijayvergia N; Ross EA; Xiu J; Swensen J; Gatalica Z; Andrake M; Dunbrack RL; El-Deiry WS
    Oncotarget; 2017 Jun; 8(25):39945-39962. PubMed ID: 28591715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of MMR gene VUS from potential Lynch syndrome patients.
    Mahdouani M; Zhuri D; Sezginer Guler H; Hmida D; Sana M; Azaza M; Ben Said M; Masmoudi S; Hmila F; Youssef S; Ben Sghaier R; Brieger A; Zeuzem S; Saad A; Gurkan H; Yalcintepe S; Gribaa M; Plotz G
    PLoS One; 2024; 19(6):e0304141. PubMed ID: 38843250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lynch syndrome: case report and review of the literature].
    Bouguenouch L; Samri I; Belhassan K; Sayel H; Abbassi M; Bennis S; Benajah DA; Ibrahimi A; Amarti A; Ouldim K
    Pan Afr Med J; 2016; 24():142. PubMed ID: 27642480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease.
    Ferguson R; Goold R; Coupland L; Flower M; Tabrizi SJ
    Am J Hum Genet; 2024 Jun; 111(6):1165-1183. PubMed ID: 38749429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline
    Huang YC; Lin PC; Wu PY; Chen NS; Shen MR; Yeh YM; Cheng YM
    Gynecol Oncol Rep; 2024 Jun; 53():101381. PubMed ID: 38584802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing.
    Bjørnstad PM; Aaløkken R; Åsheim J; Sundaram AYM; Felde CN; Østby GH; Dalland M; Sjursen W; Carrizosa C; Vigeland MD; Sorte HS; Sheng Y; Ariansen SL; Grindedal EM; Gilfillan GD
    Eur J Hum Genet; 2024 May; 32(5):513-520. PubMed ID: 38030917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Instability Promoted by Overexpression of Mismatch Repair Factors in Yeast: A Model for Understanding Cancer Progression.
    Chakraborty U; Dinh TA; Alani E
    Genetics; 2018 Jun; 209(2):439-456. PubMed ID: 29654124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate.
    Schweizer MT; Cheng HH; Tretiakova MS; Vakar-Lopez F; Klemfuss N; Konnick EQ; Mostaghel EA; Nelson PS; Yu EY; Montgomery B; True LD; Pritchard CC
    Oncotarget; 2016 Dec; 7(50):82504-82510. PubMed ID: 27756888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study.
    Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK
    Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6: hereditary cancer syndrome?
    Gutiérrez Pérez C; Rodríguez Ledesma I; Blanco Abad C; López Muñoz AM; Chivato Martín-Falquina I; Durán Domínguez M; Lastra Aras E
    Rev Esp Enferm Dig; 2024 Apr; 116(4):234-235. PubMed ID: 37314143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in Mismatch Repair Genes and Microsatellite Instability Status in Pancreatic Cancer.
    Emelyanova M; Ikonnikova A; Pushkov A; Pudova E; Krasnov G; Popova A; Zhanin I; Khomich D; Abramov I; Tjulandin S; Gryadunov D; Pokataev I
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surviving without BRCA2: MLH1 gets R-looped in to curtail genomic instability.
    Johnson N
    J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
    DeRycke MS; Gunawardena S; Balcom JR; Pickart AM; Waltman LA; French AJ; McDonnell S; Riska SM; Fogarty ZC; Larson MC; Middha S; Eckloff BW; Asmann YW; Ferber MJ; Haile RW; Gallinger S; Clendenning M; Rosty C; Win AK; Buchanan DD; Hopper JL; Newcomb PA; Le Marchand L; Goode EL; Lindor NM; Thibodeau SN
    Mol Genet Genomic Med; 2017 Sep; 5(5):553-569. PubMed ID: 28944238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer.
    Chintamani ; Jha BP; Bhandari V; Bansal A; Saxena S; Bhatnagar D
    Int Semin Surg Oncol; 2007 Feb; 4():5. PubMed ID: 17394628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.